BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23686083)

  • 1. NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product.
    Yuan W; James AW; Asatrian G; Shen J; Zara JN; Tian HJ; Siu RK; Zhang X; Wang JC; Dong J
    J Orthop Sci; 2013 Jul; 18(4):646-57. PubMed ID: 23686083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
    Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
    Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
    Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
    Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
    Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
    Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
    Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
    Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability across ten production lots of a single demineralized bone matrix product.
    Bae H; Zhao L; Zhu D; Kanim LE; Wang JC; Delamarter RB
    J Bone Joint Surg Am; 2010 Feb; 92(2):427-35. PubMed ID: 20124070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
    Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
    Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BMP-2 and combined IGF-I/TGF-ss1 application in a sheep cervical spine fusion model.
    Kandziora F; Pflugmacher R; Scholz M; Knispel C; Hiller T; Schollmeier G; Bail H; Schmidmaier G; Duda G; Raschke M; Haas NP
    Eur Spine J; 2002 Oct; 11(5):482-93. PubMed ID: 12384758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal Fusion.
    Liu L; Lam WMR; Naidu M; Yang Z; Wang M; Ren X; Hu T; Kumarsing R; Ting K; Goh JC; Wong HK
    Tissue Eng Part A; 2019 Dec; 25(23-24):1677-1689. PubMed ID: 31337284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
    Park SB; Park SH; Kim NH; Chung CK
    Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of lyophilized Nell-1 in a rat spinal fusion model.
    Li W; Lee M; Whang J; Siu RK; Zhang X; Liu C; Wu BM; Wang JC; Ting K; Soo C
    Tissue Eng Part A; 2010 Sep; 16(9):2861-70. PubMed ID: 20528102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
    J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model.
    Kaito T; Johnson J; Ellerman J; Tian H; Aydogan M; Chatsrinopkun M; Ngo S; Choi C; Wang JC
    J Bone Joint Surg Am; 2013 Sep; 95(17):1612-9. PubMed ID: 24005203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.